Would you consider HIPEC in patients with advanced ovarian cancer undergoing primary cytoreductive surgery?

Topics: Gynecologic Cancers • Ovarian Cancer • HIPEC

For instance, in patients that have not had neoadjuvant chemotherapy

Answer from: at Community Practice

HIPEC is hyperthermic intraperitoneal chemotherapy and is often administered as a onetime dose after cytoreductive surgery. HIPEC has been clinically used in malignancies that can impact the peritoneal surfaces. For the following two reasons I do not administer HIPEC during surgery for patients unde...

Comments

at Hanjani Institute
Actually, there is enough positive retrospective l...

Related Questions